![](/img/cover-not-exists.png)
MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile
Butler, M. M., Shinabarger, D. L., Citron, D. M., Kelly, C. P., Dvoskin, S., Wright, G. E., Feng, H., Tzipori, S., Bowlin, T. L.Volume:
56
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.00508-12
Date:
September, 2012
File:
PDF, 715 KB
english, 2012